CXCL9 Antikörper (AA 23-125)

Produktnummer ABIN741930

Dieses Anti-CXCL9-Antikörper ist ein Kaninchen Polyklonal-Antikörper zur Detektion von CXCL9 in WB, ELISA, IHC (p), IF (cc), IF (p) und IHC (fro). Geeignet für Human, Maus, Ratte und Schwein. Dieses Primary Antibody wurde in 8+ Publikationen zitiert.

Kurzübersicht für CXCL9 Antikörper (AA 23-125) (ABIN741930)

Target: CXCL9 (gamma-Interferon-Induced Monokine (CXCL9))

Reaktivität: Human, Maus, Ratte, Schwein

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser CXCL9 Antikörper ist unkonjugiert

Applikation: Western Blotting (WB), ELISA, Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunofluorescence (Cultured Cells) (IF (cc)), Immunofluorescence (Paraffin-embedded Sections) (IF (p)), Immunohistochemistry (Frozen Sections) (IHC (fro))

Produktdetails anti-CXCL9 Antikörper

Bindungsspezifität: AA 23-125

Kreuzreaktivität: Human, Maus, Schwein, Ratte

Homologie: Cow,Horse

Aufreinigung: Purified by Protein A.

Immunogen: KLH conjugated synthetic peptide derived from human CXCL9

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise: WB 1:300-5000
ELISA 1:500-1000
IHC-P 1:200-400
IHC-F 1:100-500
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: 1 μg/μL

Buffer: 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.

Konservierungsmittel: ProClin

Vorsichtsmaßnahmen: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

Lagerung: 4 °C,-20 °C

Informationen zur Lagerung: Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.

Haltbarkeit: 12 months

Referenzen für anti-CXCL9 Antikörper (ABIN741930)

Lee, Cho, Cho, Bae, Kim, Park: "Establishment of a chronic obstructive pulmonary disease mouse model based on the elapsed time after LPS intranasal instillation." in: Laboratory animal research, Vol. 34, Issue 1, pp. 1-10, (2018) (PubMed).

Shimoura, Nagai, Fujiwara, Jimbo, Yoshimoto, Nishigori: "Interleukin (IL)-18, cooperatively with IL-23, induces prominent inflammation and enhances psoriasis-like epidermal hyperplasia." in: Archives of dermatological research, Vol. 309, Issue 4, pp. 315-321, (2017) (PubMed).

Yada, Iimuro, Uyama, Uda, Okada, Fujimoto: "Splenectomy attenuates murine liver fibrosis with hypersplenism stimulating hepatic accumulation of Ly-6C(lo) macrophages." in: Journal of hepatology, Vol. 63, Issue 4, pp. 905-16, (2016) (PubMed).

Sawano, Shimizu, Yamada, Nanashima, Miura, Morohashi, Kudo, Hui, Kijima, Hakamada, Tsuchida: "Fatty acid synthase-positive hepatocytes and subsequent steatosis in rat livers by irinotecan." in: Oncology reports, Vol. 33, Issue 5, pp. 2151-60, (2015) (PubMed).

Zhang, Hu, Liu, Ye, Gui, Zhou, Qi, He, Wang, Wang: "CD11b deficiency suppresses intestinal tumor growth by reducing myeloid cell recruitment." in: Scientific reports, Vol. 5, pp. 15948, (2015) (PubMed).

Cai, Jiang, Pan, Chen, Zhang, Zhu, Cai, Ling, Chen, Xu, Chen: "Transcriptomic analysis of hepatic responses to testosterone deficiency in miniature pigs fed a high-cholesterol diet." in: BMC genomics, Vol. 16, pp. 59, (2015) (PubMed).

Clancy-Thompson, Perekslis, Croteau, Alexander, Chabanet, Turk, Huang, Mullins: "Melanoma Induces, and Adenosine Suppresses, CXCR3-Cognate Chemokine Production and T-cell Infiltration of Lungs Bearing Metastatic-like Disease." in: Cancer immunology research, Vol. 3, Issue 8, pp. 956-67, (2015) (PubMed).

Details zu CXCL9

Target: CXCL9 (gamma-Interferon-Induced Monokine (CXCL9))

Andere Bezeichnung: CXCL9/MIG

Hintergrund:

Synonyms: CMK, MIG, Humig, SCYB9, crg-1, C-X-C motif chemokine 9, Gamma-interferon-induced monokine, Monokine induced by interferon-gamma, Small-inducible cytokine B9, CXCL9

Background: Cytokine that affects the growth, movement, or activation state of cells that participate in immune and inflammatory response. Chemotactic for activated T-cells. Binds to CXCR3.

Gen-ID: 4283

UniProt: Q07325